Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing by Newman, M. A. et al.
Lin-28 interaction with the Let-7 precursor loop
mediates regulated microRNA processing
MARTIN A. NEWMAN,1 J. MICHAEL THOMSON,1 and SCOTT M. HAMMOND1,2
1Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, North Carolina 27599, USA
2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599, USA
ABSTRACT
A hallmark of mammalian embryonic development is the widespread induction of microRNA (miRNA) expression. Surprisingly,
the transcription of many of these small, noncoding RNAs is unchanged through development; rather, a post-transcriptional
regulatory event prevents accumulation of the mature miRNA species. Here, we present a biochemical framework for the
regulated production of the Let-7 family of miRNAs. Embryonic cells contain a Drosha Inhibitor that prevents processing of the
Let-7 primary transcript. This inhibitor specifically binds to conserved nucleotides in the loop region of the Let-7 precursor, and
competitor RNAs that mimic the binding site restore Let-7 processing. We have identified the Drosha Inhibitor as the embryonic
stem cell specific protein Lin-28. Lin-28 has been previously implicated in developmental regulatory pathways in
Caenorhabditis elegans, and it promotes reprogramming of human somatic cells into pluripotent stem cells. Our findings
outline a microRNA post-transcriptional regulatory network and establish a novel role for the miRNA precursor loop in the
regulated production of mature Let-7.
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INTRODUCTION
It is now generally appreciated that diverse forms of
double-stranded RNA (dsRNA) can act as triggers of
RNA interference (RNAi) or related homology-dependent
gene silencing pathways (Chapman and Carrington 2007).
Among these triggers are microRNAs (miRNAs), which are
single stranded, but fold into stable stem–loop structures,
providing the essential double-stranded feature. miRNAs
are encoded in the genomes of most metazoans and
function in a post-transcriptional layer of gene regulation
(for review, see Bartel 2004).
The founding miRNA, lin-4, was discovered in
Caenorhabditis elegans as a mutant that displayed hetero-
chronic, or developmental timing, defects (Lee et al. 1993;
Wightman et al. 1993). The activity of this small RNA is
mediated largely through repression of two well established
target mRNAs, lin-14 and lin-28 (Ambros 1989). A second
miRNA, let-7, was later identified as a heterochronic
mutant (Reinhart et al. 2000). Surprisingly, this miRNA
has complete nucleotide conservation from C. elegans to
humans, suggesting an ancient biological role (Pasquinelli
et al. 2000). More recently, thousands of miRNAs have
been identified across many phyla. While few validated
mRNA targets have been assigned to these miRNAs,
computational predictions suggest that each miRNA has
tens to hundreds of targets, underscoring their immense
potential for controlling gene expression (Bartel 2004).
The initiation of miRNA-dependent gene regulation is
the transcription of a primary transcript, or pri-miRNA
(for review, see Kim 2005). This RNA is typically thousands
of nucleotides long and is often capped, spliced, and
polyadenylated. The stem–loop structure is excised by the
ribonuclease enzyme Drosha, liberating the precursor, or
pre-miRNA. After export out of the nucleus, the precursor
is further processed by the enzyme Dicer. The resultant
siRNA-like molecule is loaded into the RNAi effector
complex RISC, where it directs nucleolytic degradation
and translational repression of target mRNAs.
While hundreds of miRNAs have been identified in the
human and mouse genomes, the biological role of most
miRNAs is unknown. However, numerous studies have
linked miRNA function to the regulation of cell growth and
differentiation (for review, see Esquela-Kerscher and Slack
2006). For example, the miRNA cluster miR-17-92 is highly
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expressed in a wide range of cancers, and ectopic expression
of this candidate oncogene promotes cancer in several
mouse models. This miRNA cluster is also highly expressed
in early mouse development, and at least one study has
confirmed its role in preventing the differentiation of
progenitor cells (Lu et al. 2007). In contrast to these
‘‘oncomiRs,’’ a large number of miRNAs, including the
Let-7 family, are depleted in cancer. Let-7 itself has been
shown to target the oncogenes Ras, Myc, and HMGA2, and
expression of this miRNA inversely correlates with disease
severity (Esquela-Kerscher and Slack 2006; Lee and Dutta
2007; Mayr et al. 2007). Interestingly, global down-regulation
of all miRNAs promoted disease in a mouse model for
lung carcinoma, suggesting that the overall tumor-suppressive
functions of miRNAs are more important than the oncogenic
functions of, for example, miR-17-92 (Kumar et al. 2007).
RESULTS
Regulated microRNA biogenesis
The widespread alterations in miRNA expression in cancer
prompted us to investigate the regulatory mechanisms
responsible for their production. Our initial studies focused
on the Let-7 family, where we previously demonstrated that
induction of this miRNA family during mouse embryo-
genesis occurs at a post-transcriptional stage (Thomson et al.
2006). Since we observed a large amount of primary
transcript in the absence of precursor and mature species,
we predicted that a block was in place at the Drosha
endonuclease processing step. We tested this directly using
an established cell-free assay that reports Drosha activity
(Lee et al. 2002). We compared the processing efficiency of
a regulated miRNA, Let-7g, with a miRNA that is readily
processed in all known cell types, miR-17. We incubated
radiolabeled primary transcripts for these miRNAs in nu-
clear extracts prepared from the mouse embryonal carci-
noma cell line P19. We had previously shown that this cell
line exhibits regulated processing of Let-7, as it has abundant
pri-Let-7 but no detectable mature Let-7 (Thomson et al.
2006). As a control, we performed assays in extracts derived
from HeLa cells, which have abundant mature Let-7, and
thus are competent for Let-7 processing. Nuclear extracts
derived from HeLa cells were efficient at processing both
Let-7g and miR-17, with approximately equal amounts of
each precursor product being generated (Fig. 1). While
several RNA species are generated after the Drosha reac-
tion, we were able to confirm the identity of the correct
precursor reaction products by Northern blot hybridization
of unlabeled products (Supplemental Fig. 1).
While the control nuclear extract was competent for
both Let-7g and miR-17 processing, extracts derived from
undifferentiated P19 cells were inefficient at processing
Let-7g (Fig. 1). We calculated the ratio of Let-7g product to
miR-17 product to generate a Let-7 processing efficiency.
Undifferentiated P19 cells were z10-fold less efficient at
processing Let-7g compared with miR-17.
These data demonstrate that Drosha processing of Let-7
is less efficient in embryonic cells, but they do not dis-
criminate between an activator present in the HeLa extract
or an inhibitor present in the P19 extract. Therefore, we
performed the same assay in a 1:1 mixed extract of P19 and
HeLa cells. The mixed extract assay yielded product ratios
similar to the P19 extract alone, indicating that the reg-
ulatory factor is dominant in P19 cells and is therefore an
inhibitor of Let-7 processing (Fig. 1). To rule out the pos-
sibility that the regulatory event was due to the modifica-
tion of Drosha itself, we immunoprecipitated the Drosha
protein from undifferentiated P19 nuclear extracts. This
purified protein was no longer subject to regulated pro-
cessing, as it was fully competent for Let-7 processing (Fig. 1).
While our data demonstrate a regulatory point at the
Drosha processing step, this does not preclude regulation at
other steps in miRNA biogenesis. Specifically, regulation of
Let-7 biogenesis at the Dicer processing step has been
reported (Wulczyn et al. 2007).
microRNA regulatory sequences
Since Drosha protein that had been immunopurified had
lost the regulatory factor, the most logical conclusion of
our data was that a Drosha Inhibitor, present in the P19
FIGURE 1. Embryonic cells contain a Drosha Inhibitor that specif-
ically regulates Let-7. (Left) Radiolabeled pri-miRNA substrates
corresponding to Let-7g and miR-17 were incubated in P19 or HeLa
nuclear extracts, as indicated. (Right) Drosha protein, or mock, was
immunoprecipitated from P19 nuclear extracts with a polyclonal
antibody. Immobilized protein was incubated with Let-7g and miR-17
pri-miRNA substrates, as indicated. Drosha endonuclease products
were resolved on a denaturing polyacrylamide gel. (Arrows) Pro-
duction of Let-7g and miR-17 precursors. A labeled RNA oligonu-
cleotide ladder is shown for size reference.
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extract, was interacting directly with the Let-7 primary
transcript. Alignment of the stem–loop precursors for the
Let-7 family revealed highly conserved nucleotides within
the loop region (Fig. 2A). These sequence elements do not
contribute to mRNA targeting; therefore, we reasoned they
maintained conservation due to a regulatory role. We
undertook several approaches to test whether the loop
sequences of Let-7 were essential for regulated Drosha
processing. Our first strategy was to build chimeric Let-7g
primary transcripts that contained loop regions from other,
unregulated miRNAs. We did detect weak processing in
P19 cells, though it was unclear if these altered stem–loops
were interacting properly with the processing machinery
(data not shown). As an alternative, we employed site-
directed mutagenesis to alter conserved residues in the loop
(for sites, see Fig. 2A). Importantly, these mutations did
not affect folding of the stem–loop structure based on
computational folding algorithms (mFOLD). Pri-Let-7g
transcripts containing the SD1 or
SD2 mutations were partially re-
leased from the Drosha processing
block as evidenced by increased pri-
Let-7g cleavage in P19 nuclear
extracts (Fig. 2B). The SD3 and
SD4 mutations had no effect (data
not shown). Mutation at both the
SD1 and SD2 sites further released
the processing block. Importantly,
these mutations did not impair gen-
eral Drosha cleavage, as processing
was unaffected in HeLa extracts.
While these data suggest the re-
quirement for these loop nucleotides,
this does not formally prove that
the Drosha Inhibitor interacts with
the loop. To establish this, we
designed competitor RNAs based
on Let-7 stem–loop sequences. If
the Drosha Inhibitor was binding
to the loop region, we reasoned that
these competitor RNAs should divert
the Inhibitor away from the Let-7
primary transcript, restoring pro-
cessing in P19 cells. We tested com-
petitors corresponding to all 11 Let-7
family members (not including miR-
98). Competitors that matched Let-7
stem–loop sequences restored Dro-
sha processing of Let-7g without
affecting production of miR-17 (data
not shown). The most effective com-
petitor was based on Let-7d. Figure
2C illustrates restoration of Let-7g
processing in P19 nuclear extracts in
the presence of Let-7d stem–loop
competitor. Competitors based on
an unregulated miRNA, miR-17,
had no effect on Let-7 processing
(Fig. 2C). Interestingly, an oligonu-
cleotide corresponding to the loop
alone was highly effective, suggesting
that a stem–loop structure is not
essential for interaction with regu-
latory proteins (Fig. 2C).
FIGURE 2. The loop region of Let-7 interacts with the Drosha Inhibitor. (A) The sequence
alignment of Let-7 family members is shown. (Blue text) Mature miRNA sequence; (green text)
the complementary stem strand (not exactly the star strand); (gray boxes) regions of homology;
(arrows) nucleotides that were mutagenized. Sequence changes are indicated below the alignment.
(B) Wild-type (WT) or mutant pri-Let-7g substrates were combined with the pri-miR-17 substrate
and incubated in a P19 or HeLa nuclear extract. Drosha products were resolved and are indicated.
(C) Pri-miRNA substrates for Let-7g and miR-17 were combined and incubated in P19 nuclear
extracts. Competitor RNA transcripts corresponding to the loop plus 12 nt of each stem, or
competitor 29-O-methyl oligonucleotides, were included at 10, 50, and 250 nM final concentra-
tion. In one case, the oligonucleotide had a 39 Biotin moiety. The left lane had no competitor.
Drosha products were resolved on a denaturing polyacrylamide gel. (Arrows) Precursor products.
Lin-28 regulation of Let-7 processing
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The Drosha Inhibitor
We next investigated the nature of the Drosha Inhibitor.
We designed an affinity purification strategy using the Let-
7d loop as a capture reagent. We confirmed that a linear
sequence, comprised of loop sequence only, fully 29-O-
methyl modified (for stability), and linked to a biotin
moiety, was able to restore Drosha processing of Let-7g
when used as a competitor (Fig. 2C). We bound this
capture probe to streptavidin-agarose and isolated binding
proteins from P19 nuclear extracts. Proteins were identified
by peptide mass fingerprinting. A large number of proteins
specifically bound to the Let-7 loop probe, as shown in
Figure 3A. Many of the proteins belong to the hnRNP
family. This family of RNA binding proteins has diverse
roles in RNA splicing and has been implicated in the reg-
ulation of miR-18a processing (Guil and Caceres 2007).
Interestingly, we also captured the RNA binding proteins
Lin-28 and Lin-28B. This protein family was originally
identified in C. elegans as a genetic mutant that exhibited
abnormal cell lineage (Ambros and Horvitz 1984). Family
members are characterized as having a cold shock domain
and two zinc finger domains, a unique domain organiza-
tion among all known RNA binding proteins (Moss et al.
1997). The biochemical activity of LIN-28 is not well
characterized, though it has been suggested to regulate
translation of specific mRNAs (Polesskaya et al. 2007).
We confirmed the interaction between Lin-28 and the
Let-7 loop by UV-crosslink analysis. Radiolabeled Let-7
stem–loop RNA specifically crosslinked a protein in P19
nuclear extracts that matched the size of Lin-28 (Fig. 3B).
We confirmed the identity of the protein by immunopre-
cipitation of crosslink reactions with an antibody to Lin-28.
As evident in Figure 3B, one labeled protein of the correct
size was recovered from Let-7 crosslink reactions, but no
detectable protein was immunoprecipitated from the con-
trol reaction. Importantly, the Let-7/Lin-28 interaction was
sensitive to the presence of excess competitor Let-7 stem–
loop RNA. Control competitors did not disrupt the Lin-28/
Let-7 interaction.
While these data demonstrated interaction of Lin-28
with the Let-7 stem–loop, they did not demonstrate a
regulatory role. To test this, we introduced Lin-28 and Lin-
28B into NIH-3T3 cells by retroviral transduction and
measured steady-state levels of mature miRNAs. Micro-
array analysis indicated that most miRNAs were unchanged,
except for a cluster of miRNAs reduced in cells expressing
either Lin-28 or Lin-28B (Fig. 4A). As predicted, this clus-
ter included most Let-7 family members. We confirmed
miRNA expression changes by RT-PCR (Fig. 4B). This
method is more sensitive and provides greater discrimina-
tion among the highly related Let-7 family members. Let-7f,
Let-7g, and Let-7i were repressed 240-, 90-, and 195-fold,
respectively, with other family members repressed to a
lesser degree. We measured steady-state levels of unrelated
miRNAs and found no significant change. Importantly, the
reduction in Let-7g was at a post-transcriptional step, as
the level of the primary transcript was not decreased to the
same magnitude (2.8-fold). Northern
blot analysis indicated no accumulation
of Let-7g precursor, consistent with a
block at the Drosha processing step
(Fig. 4C). While it is formally possible
that Lin-28 promotes a block at the
Dicer processing step, this would
require an increase in precursor turn-
over at the same rate as precursor pro-
duction, since no alteration in precursor
steady state levels is detected.
To further confirm a role for Lin-28
in the repression of Let-7 expression, we
performed RNAi knockdown of Lin-28
in P19 embryonic cells. Two siRNAs
that reduced protein levels >90% re-
leased the processing block and led to
increased mature Let-7 (Fig. 4D; Sup-
plemental Fig. 3). As above, Let-7 family
members had differential response to
siRNA knockdown, with Let-7g, Let-7i,
Let-7a, and Let-7f the most affected.
Our final goal was to demonstrate the
direct regulation of Let-7 processing by
Lin-28. We generated recombinant Lin-
28 and an unrelated RNA binding protein
FIGURE 3. The RNA binding protein Lin-28 specifically binds to the Let-7 loop region. (A)
Oligonucleotide capture probes corresponding to the Let-7d loop or a random (control)
sequence, fully 29-O-methyl modified, 39 Biotin linked, were bound to streptavidin agarose.
Proteins were captured from P19 nuclear extracts, were resolved on a 4%–20% polyacrylamide
gel, and were stained with coomassie blue. Proteins were isolated and identified by MALDI-
TOF fingerprinting. (B) Radiolabeled RNA probes corresponding to the Let-7d stem–loop or
miR-20a stem–loop were incubated with P19 nuclear extracts. Unlabeled Let-7d loop or
control oligonucleotide competitors were included as indicated at 12.5, 125, or 1250 nM.
Proteins were crosslinked to probes with UV light. Lin-28 was immunoprecipitated from
crosslink reactions with a polyclonal antibody. Total extract (IP input) and immunoprecipi-
tates were resolved, as indicated, on a polyacrylamide gel.
Newman et al.
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FIGURE 4. Lin-28 expression blocks production of Let-7. (A) NIH-3T3 cells were transduced with MSCV retroviral constructs that drive
expression of Lin-28, Lin-28B, or control, as indicated. Steady-state miRNA expression levels were quantitated using a custom microarray
platform 10 d post-infection. Normalized measurements were hierarchically clustered and are plotted as a heat map. (Yellow) High expression,
(blue) low expression, relative to the mean. (Red font) Let-7 family members. (B) Steady-state miRNA expression levels from NIH-3T3 cells
expressing Lin-28, Lin-28B, or control were quantitated by real-time RT-PCR. U6 snRNA was used as the reference. Expression of pri-Let-7g was
also quantitated by real-time RT-PCR. b2-microglobulin was used as the reference. (C) Let-7g precursor and mature species in NIH-3T3 cells
expressing Lin-28, Lin-28B, or control were analyzed by Northern blotting. (D) P19 cells were transfected with siRNAs targeting Lin-28. Two
effective siRNAs were used alone or in combination. Five days post-transfection, mature miRNA levels were measured by real-time RT-PCR. U6
was used as a reference. Expression of pri-Let-7g was also quantitated by real-time RT-PCR. b2-microglobulin was used as the reference.
Lin-28 regulation of Let-7 processing
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NF-45 in Escherichia coli and introduced these purified
proteins into our cell free Drosha assay (for recombinant
proteins, see Supplemental Fig. 2). As described above,
HeLa extracts will process Let-7g with similar efficiency as
miR-17. As shown in Figure 5A, Lin-28 inhibited process-
ing of Let-7g without affecting processing of miR-17. This
was not a nonspecific effect of RNA binding as the control
protein (NF-45) had no effect of processing of either sub-
strate. To further support our conclusions, we removed
endogenous Lin-28 from the P19 embryonic cell extract by
immunodepletion. This enabled processing of Let-7 (Fig. 5B).
DISCUSSION
Our results outline a regulatory mechanism for the pro-
duction of the Let-7 family of miRNAs. The primary tran-
scripts for these miRNAs are uniformly expressed during
embryonic development. The interaction of a Drosha
Inhibitor with the loop structure of the pri-miRNAs leads
to a block at the Drosha processing step. We have identified
conserved nucleotides within the loop that are essential for
the Drosha processing block. This is the first report of cis-
regulatory elements within the Let-7 primary transcript.
While our work focused on the loop region of Let-7, it is
interesting that sequence conservation extends outside the
stem–loop precursor. Figure 6 illustrates that extensive
vertebrate conservation is present in sequences flanking
the precursor. This sequence may be important for splicing
of the host gene Wdr82. However, the proximity to the
stem–loop suggests these elements play a regulatory role in
some aspect of miRNA function. In further support of this,
Let-7 family members that are not intronic (for example,
Let-7i, as shown in Fig. 6) have conserved sequence ele-
ments flanking the stem–loop.
We identify Lin-28 as a protein that interacts with the
loop region of Let-7. This interaction is specific for Let-7
family members and has a dissociation constant in the high
nanomolar range, based on competitor assays (Fig. 3B) and
fluorescent anisotropy binding assays (not shown). The inter-
action of Lin-28 with Let-7 inhibits Drosha processing.
This RNA binding protein is highly expressed in early devel-
opment and has been proposed as a marker for ES cells
(Yang and Moss 2003; Richards et al. 2004). Differentiation
of P19 cells with retinoic acid leads to robust induction of
Let-7; Lin-28 protein decays at the time point that Let-7
processing is enabled (Lee et al. 2005; Wu and Belasco
2005). We propose that a similar decay of this protein dur-
ing embryonic development is what allows Drosha process-
ing of Let-7 and eventual production of the mature species.
While it is clear that Let-7 processing is negatively
regulated by Lin-28, is this the primary mode of regulation
for the production of this miRNA family? We have pre-
viously reported that Let-7 processing efficiency increases
>1000-fold during mammalian development (Thomson et al.
2006). Our overexpression studies, however, perturb Let-7
levels z100-fold. It is probable that we are not achieving
high enough expression levels to fully recapitulate embry-
onic cells, and Western blot analysis confirms this (Sup-
plemental Fig. 4). Similarly, our siRNA knockdown studies
do not fully eliminate Lin-28 expression, and it is possible
that remaining Lin-28 protein has some repressive function
(Supplemental Fig. 3). These points suggest we have
identified the major regulatory point in Let-7 production,
though we cannot rule out contributions at Dicer process-
ing or at pri-Let-7 transcription, both of which have been
reported (Wulczyn et al. 2007; Chang et al. 2008).
Recently, an independent study has demonstrated that
Lin-28 selectively inhibits processing of Let-7 (Viswanathan
et al. 2008). Similarly, this work suggested inhibition at the
Drosha processing step, lending further support to our
model proposed herein.
The exact mechanism whereby Lin-28 inhibits Drosha
processing is not known. Its high affinity binding to Let-7
may simply block access of Drosha or DGCR8 to the pri-
miRNA. This binding event may promote turnover of the
pri-miRNA, as there is no accumulation of this RNA
species under conditions where processing is inhibited.
Alternatively, pri-miRNAs may have a short half-life under
all conditions and therefore are degraded if not rapidly
processed by the Drosha machinery. A final possibility is
that the Lin-28/Let-7 complex is exported out of the
nucleus and shuttled to P-bodies for degradation. Lin-28
is known to shuttle between the nucleus and cytoplasm and
FIGURE 5. Lin-28 is necessary and sufficient for regulated Let-7
processing. (A) Pri-miRNA substrates for Let-7g and miR-17 were
combined and incubated in HeLa nuclear extracts. Purified, recombi-
nant NF-45 (control) or Lin-28 were included at 2, 20, and 200 ng per
reaction. Drosha products were resolved on a denaturing polyacryl-
amide gel. (Arrows) Precursor products. Recombinant protein was
produced in E. coli. (B) (Left lanes) Polyclonal Lin-28 antibody, or
mock, was bound to protein A sepharose. P19 nuclear extracts were
incubated with immobilized antibody. Resultant immunodepleted
extracts were incubated with pri-miRNA substrates for Let-7g and
miR-17. (Right lanes) Recombinant Lin-28 was added back to
immunodepleted reactions at 100 ng/mL final concentration. Drosha
products were resolved on a denaturing polyacrylamide gel. (Arrows)
Precursor products. Recombinant protein was produced in HEK-293
cells.
Newman et al.
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has been localized to P-bodies, lending support to this
hypothesis (Balzer and Moss 2007).
The regulation and developmental expression of the
mammalian Lin-28 closely parallels that of the C. elegans
ortholog, suggesting it performs a similar function in that
organism. Expression of let-7 during C. elegans larval devel-
opment is known to be regulated at transcription (Johnson
et al. 2003). In lin-28 mutants, however, the production of
mature let-7 is accelerated by one larval stage. Similarly, in
lin-4 mutants, which have elevated expression of lin-28, the
production of mature let-7 is delayed (Johnson et al. 2003).
While it is not known if these effects are a result of direct
interaction between the lin-28 protein and the let-7 primary
transcript, it is possible that the mechanism we report here
is conserved from C. elegans to mammals.
The role of Lin-28 in mammalian development is not
known. However, a combination of Lin-28, Nanog, Oct-3/4,
and Sox2 are sufficient to reprogram human somatic cells to
pluripotent stem cells (Yu et al. 2007). The role of Nanog, Oct-
3/4, and Sox2 in maintaining pluripotency is well established
(Pan and Thomson 2007). The additional requirement for
Lin-28 in these studies suggests that restoration of the Let-7
processing block is an essential step for reprogramming stem
cells. These findings strongly implicate miRNA expression
patterns as important determinants of stem cell fate.
MATERIALS AND METHODS
Pri-microRNA substrates
Substrate constructs (stem–loop with z10 nucleotides [nt] of
ssRNA flanking region) were created by the polymerase chain








Forward and reverse primers added ssRNA flanks as well as 59











The resulting PCR products were digested and cloned into a MSCV-
splice-donor/splice-acceptor vector (SDSA3.0) (J.M. Thomson and
S.M. Hammond, unpubl.) based on the MSCV-puro vector (Clontech).
Pri-microRNA transcription templates were created from the
pri-microRNA constructs described above; PCR was employed to
add on a 59 T7 promoter (59-TCGTAATACGACTCACTATA
GGGTCCGCTAGCCTAGCTACTACCA-39 and 59- ATAAGTAT
GATATTGTCAAGGAAACCC-39). Radiolabeled pri-microRNAs
were created using T7 RNA polymerase (NEB) in accordance with
the manufacturer’s instructions. The resulting pri-microRNA
substrates were (pri-microRNA sequences are in bold type;









FIGURE 6. Extensive sequence conservation of pri-Let-7. The genomic locus of the mouse pre-Let-7g and pre-Let-7i stem–loop sequence are
shown, with 600 nt flanking on each side included. The conservation plot of 30 vertebrate species is shown. Data were obtained from the UCSC
genome browser, July 2007 release.
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Cell culture and nuclear extract preparation
P19 cells were differentiated for 10 d in retinoic acid, as described
(Thomson et al. 2006). Undifferentiated and differentiated P19
cells and HeLa S3 nuclear extracts were prepared as previously
described (Dignam 1990). In brief, cell pellets, washed once in
phosphate buffered saline (PBS), were resuspended in 2.5 volumes
of Buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2,
0.2 mM EDTA, 1 mM dithiotreitol [DTT], 1 mM phenylmethyl-
sulfonyl fluoride [PMSF], 20% glycerol, and Complete protease
inhibitors [CPI, Roche]) and incubated for 10 min on ice. Cells
were then lysed using 5–10 passes in a dounce homogenizer.
Nuclei were centrifuged at 1200 rpm for 5 min, followed by cen-
trifugation at 15,000g for 15 min, and the resulting supernatant
was discarded. Pelleted nuclei were extracted in buffer C (20 mM
HEPES, pH 7.9, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1
mM DTT, 1 mM PMSF, 20% glycerol, and CPI) for 30 min at 4°C
(3 mL of buffer C was used per 1 3 109 cells). Nuclear debris was
then pelleted by centrifugation at 15,000 rpm for 30 min, and the
resulting nuclear extract was dialyzed for 5 h against >50 volumes
of buffer D (20 mM HEPES, pH 7.9, 100 mM KCl, 1.5 mM MgCl2,
0.2 mM EDTA, 1 mM DTT, 1 mM PMSF, and 20% glycerol).
Cell-free Drosha processing assay
Drosha assay reactions were carried out as previously described
with some modifications (Lee et al. 2002). 1 3 105 cpm each of
pri-Let-7g and pri-miR-17 transcripts were combined and incu-
bated with 100 mg of nuclear extract (where indicated, either
100 mg of P19 extract, 100 mg of differentiated P19 extract, 100 mg
of HeLa extract, or 50 mg P19 + 50 mg HeLa extract) + 0.1mL of
RNasin (Promega) for 30 min at 37°C. RNA was isolated using
Trizol and precipitated in cold isopropanol. RNA pellets were
washed once in 70% ethanol and resuspended in 15 mL of form-
amide loading buffer. Processed pri-microRNA products were
resolved on a 12.5% acrylamide–8 M urea sequencing gel and
visualized by autoradiography using a Storm PhosphorImager
(GE Life Sciences); pre-microRNA band intensities were quanti-
tated using Imagequant software (GE Life Sciences). A molecular
weight ladder of radiolabeled, concatamerized RNA oligos was
used to determine the size of the pre-microRNA products.
Drosha immunoprecipitation
For Drosha assays using immunoprecipitated Drosha, we first
generated rabbit polyclonal anti-Drosha antibody using the pep-
tide sequence CPEEAEDIKK. 250 mL of P19 nuclear extract was
pre-cleared with 25 mL of protein-A sepharose and incubated
either with 40 mL of affinity-purified Drosha antibody and 45 mL
of packed protein-A sepharose or with protein-A sepharose alone.
Igepal CA-630 (Sigma) was added to 0.5% v/v, and immunopre-
cipitation reactions were incubated for 1 h at 4°C. Beads were then
washed three times in buffer D + 0.5% Igepal.
Individual Drosha reactions were carried out as described above
using 10 mL of immobilized protein from each immunoprecipi-
tation reaction, pri-miRNA substrates individually or combined,
and buffer D and 1 mL of RNasin.
Drosha assay Northern blot
To identify pre-microRNA products, Drosha assays were carried
out as described above except that 0.15 mg of unlabeled pri-
microRNA was individually incubated in HeLa extract. Separated
RNA products were then transferred onto Nylon (Amersham)
which was then UV crosslinked and hybridized to locked nucleic
acid (LNA) probes (Integrated DNA Technologies) that were
labeled on the 59 end with T4 polynucleotide kinase (NEB).
Hybridizations occurred overnight at 65°C, were washed three
times at 65°C in 0.43 SSC + 0.2% SDS, and cross-reacted bands
were visualized by autoradiography.
Northern probe sequences are listed below (lowercase denotes
LNA; uppercase denotes DNA):
Let-7g: 59-ACTgTaCaAaCgAcTaCcTcA-39; and
miR-17-3p: 59-ACAaGtGcCtTcAcTgCaGt-39.
Stem–loop RNA competitor assay
Drosha reactions were pre-incubated on ice for 30 min with
unlabeled microRNA stem–loop RNAs added to final concen-
trations of 12.5 nM, 125 nM, and 1250 nM, respectively. The
competitor RNAs were either 29-O-methlyated RNA oligos
(Dharmacon) or were in vitro transcribed from long double-
stranded DNAs (dsDNAs) encoding a T7 promoter, the upper 10
base pairs of stem, and the loop of the indicated pri-microRNA.
The dsDNAs were created by annealing a T7 adapter primer to a
longer microRNA primer, followed by a brief PCR extension step
with Pfu DNA polymerase (Promega) (5 min, 95°C; 1 min, 59°C;
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Lin28 immunodepletion Drosha assay
Protein A-sepharose beads were washed three times in ‘‘Hi DTT’’
immunoprecipitation (IP) buffer (20 mM HEPES, pH 7.6, 2 mM
MgCl2, 150 mM NaCl, 10 mM DTT, 1 mM PMSF, 0.5% NP-40)
followed by five washes in IP buffer (20 mM HEPES, pH 7.6,
2 mM MgCl2, 150 mM NaCl, 1 mM DTT, 1 mM PMSF, 0.5%
NP-40). 15 mL of anti-Lin-28 antibody (Abcam) was prebound to
30 mL of protein A sepharose beads (Sigma) for 1 h at 25°C in
IP buffer, followed by extensive washing with buffer D + 0.5%
NP-40. 100 mL of P19 nucelar lysate (5 mg/mL) was diluted two-
fold in buffer D + 2 mL of RNasin and rotated overnight at 4°C
with either the antibody–beads mixture or beads alone as a mock.
Recombinant protein competitor assay
Drosha assays were carried out as described above except that,
where indicated, 2 ng, 20 ng, and 200 ng of recombinant protein
was added to HeLa extract/pri-microRNA mixtures before the
37°C incubation step.
RNA affinity pulldown
30 mL of 100 mM Let-7d Loop biotinylated 29-O-methylated RNA
oligonucleotide, (59-UUmAmGmGmGmCmAmGmGmGmAmU
mUmUmUmGmCmCmCmAmCmAmAmGmGmAmGmGmU-
18s-Bi-39, Dharmacon) or a nonspecific control oligo (59-Bi-18S-
18S-mAmUmAmAmGmUmAmUmGmAmUmAmUmUmGmU
mC-39, Dharmacon) was bound to 150 mL of streptdavidin-
agarose beads (Fluka) for 1 h at 37°C in ‘‘high salt’’ buffer D
(+1 M KCl). Bead–oligo mixtures were washed three times in
buffer D+T. 15 mg of P19 cell nuclear extract (equivalent to 1 3
109 cells) was diluted up to 20 mL in buffer D+T, pre-cleared with
streptavidin agarose beads, and incubated with bead–oligo mix-
tures for 3 h at 25°C. Beads were then washed six times in buffer
D+T, and bound proteins were eluted using SDS protein loading
buffer + 50 mM DTT. Proteins were separated on a 4%–20% pre-
cast polyacrylamide gel (Jule Biotechnologies) and stained with
Coomassie brilliant blue G-250 (Bio-Rad); appropriate bands
were excised and submitted to the UNC–Duke Michael Hooker
Proteomics Facility for tryptic digestion and MALDI-TOF foot-
printing.
UV crosslinking
Crosslinking experiments were carried out essentially as pre-
viously described (Myer et al. 1997). In brief, 50 mg of P19
nuclear lysate, 3 mg of yeast tRNA, and 5 3 105 cpm of hsa-Let-7d
or hsa-miR-20a loop probes (same competitor RNA sequences as
in the ‘‘stem–loop RNA competitor assay’’ above) were combined
and adjusted to a volume of 14 mL with buffer D (20 mM HEPES,
pH 7.9, 20% glycerol, 100 mM KCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 1 mM DTT, 1 mM PMSF). Reaction mixtures were
incubated for 30 min at 25°C, followed by irradiation with 1
Joule of UV light. Each sample was then incubated with 10 mg of
RNase A for 30 min at 37°C. The samples were then either
prepared for immunoprecipitation (see below) or boiled in SDS
protein loading buffer for 5 min (‘‘input’’ samples). Where
indicated, 29-O-methyl oligonucleotides were added to the final
concentration of 12.5 nM, 125 nM, or 1250 nM to the reaction
mixture and pre-incubated for 30 min at 25°C prior to the
addition of the labeled probe. 29-O-methyl competitor sequences
are given below:







RNase A-treated samples were boiled in TSD buffer (50 mM Tris-
Cl, pH 7.5, 1% SDS, 5 mM DTT) for 10 min and diluted 10-fold
in TNN buffer (50 mM Tris-Cl, pH 7.5, 250 mM NaCl, 5 mM
EDTA, 0.5% NP-40, and complete protease inhibitor [Roche]).
Diluted lysates were pre-cleared with protein-A sepharose beads
(Sigma) followed by immunoprecipitation overnight at 4°C with
anti-Lin28 antibody (Abcam) and protein A-beads or with pro-
tein-A beads alone (‘‘mock’’ immunoprecipitation). Protein-
bound beads were washed extensively with cold TNN buffer;
proteins were eluted by boiling SDS protein loading buffer and
were separated on a 12% SDS-PAGE gel, which was subsequently
fixed and dried down. Radiolabeled proteins were visualized by
autoradiography.
Recombinant proteins
cDNAs were amplified from full-length ESTs coding for NFAT-45
and Lin-28 as well as a partial EST for Lin28B (Open Biosystems)
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Flag-tagged cDNAs were cloned into pcDNA 3.0 using 59 EcoRI
and 39 NotI restriction sites. cDNAs were subsequently subcloned
into pMSCV-puro-IRES-GFP (He et al. 2005). For overexpression
studies, NIH-3T3 cells were transduced using virus generated with
the LinXE ecotropic packaging line. Cells were selected with puro-
mycin. Ten days post-infection, total RNA and protein samples
were isolated using Trizol and SDS loading buffer, respectively.
MicroRNA expression levels were examined by quantitative real-
time PCR (qRT-PCR) as well as by microRNA microarray as pre-
viously reported (Thomson et al. 2004, 2006). Protein overexpression
was verified by Western blot with a Lin-28 antibody (Abcam).
Purification of His-tagged Lin-28 and NF-45
The following primers were used to amplify mouse coding








PCR products were inserted into the pET28b vector (Novagen)
after NcoI/XhoI (vector; Lin28) or BsmFI/XhoI (NF45) digestion.
BL21 (DE3) pRIL E. coli (Stratagene) served as the host for protein
expression. Briefly, positive clones were grown in 1 L of LB to a
density of 0.6 OD600 at which time recombinant protein was
induced by the addition of 0.25 mM IPTG and allowed to grow
for an additional 3 h. Cells were harvested by centrifugation, and
cell pellets were suspended in 30 mL of Talon resin equilibration/
wash buffer, 50 mM sodium phosphate, pH 7.0, 300 mM NaCl
(Clontech). Cells were lysed by sonication and cleared by
centrifugation. The cell lysate was incubated with 5 mL of
equilibrated Talon resin beads and allowed to bind for 1 h at
4°C. The resin was batch washed 3 3 20 min in 30 mL of
equilibration/wash buffer and applied to a disposable column. The
protein was eluted along a 50-mL gradient of equilibration buffer
containing 0–200 mM imidazole, and fractions were collected.
Pure fractions were combined and dialyzed in buffer D (20 mM
Hepes, pH 7.9, 100 mM KCl, 0.2 mM EDTA, 1.5 mM MgCl2, 1
mM PMSF, 1 mM DTT, and 20% glycerol). Aliquots were stored
at 80°C.
Purification of Flag-tagged recombinant Lin-28
Twenty 10-cm plates of HEK293 cells were transiently transfected
with either Flag-tagged NFAT-45, Lin28, or Lin28B overexpres-
sion constructs using Fugene 6 (Roche) according to the manu-
facturer’s instructions. After 48 h, cells were harvested by scraping
in cold PBS, centrifuged at 1200 rpm for 5 min, and lysed in IP
buffer. Lysates were pre-cleared with 50 mL of protein A beads for
1 h followed by immunoprecipitation with 50 mL of M2 Flag
agarose beads (Sigma) overnight at 4°C. Beads were then pelleted
and washed 10 times in cold buffer D followed by elution with
Flag peptide (Sigma) at 400 mg/mL in buffer D. Purity of eluted
proteins was verified by SDS-PAGE followed by coomassie blue
staining of the gel.
Lin-28 knockdown/overexpression studies
P19 cells were seeded in six-well plates at z40% confluency and
2 h later were transfected with siRNAs to either GAPDH or Lin-28
(Dharmacon) using Lipofectamine 2000 (Invitrogen) as instructed
by the manufacturer. Total RNA and protein was isolated z72 h
later using Trizol and SDS loading buffer, respectively. microRNA
expression levels were examined by quantitative real-time PCR
(qRT-PCR) (Thomson et al. 2006). The siRNA sequences were:
si #2: 59-ggagacaggugcuacaacuuu-39;
si #9: 59-ugacguaucuugugcguuuuu-39; and
si #12: 59-aaaugugucucacggguuuuu-39.
Lin-28 and Lin-28B were ectopically expressed using MSCV
retroviral expression constructs. MSCV retrovirus was transduced
into NIH-3T3 cells and cells were selected with puromycin. Ten
days post-infection, cells were harvested and miRNA expression
levels were characterized by microarray analysis and real time
RT-PCR essentially as described (Thomson et al. 2004, 2006).
Northern blot analysis was performed as described, using a
radiolabeled LNA probe for Let-7g (Thomson et al. 2006).
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